Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulse Biosciences (PLSE) Change in Acquisitions & Divestments (2020 - 2021)

Pulse Biosciences (PLSE) has 2 years of Change in Acquisitions & Divestments data on record, last reported at $8.0 million in Q1 2021.

  • For Q1 2021, Change in Acquisitions & Divestments fell 40.74% year-over-year to $8.0 million; the TTM value through Dec 2021 reached $8.0 million, down 77.14%, while the annual FY2021 figure was $8.0 million, 77.14% down from the prior year.
  • Change in Acquisitions & Divestments reached $8.0 million in Q1 2021 per PLSE's latest filing, down from $30.5 million in the prior quarter.
  • Across five years, Change in Acquisitions & Divestments topped out at $30.5 million in Q4 2020 and bottomed at -$9.0 million in Q2 2020.